Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Stage Identification and Engagement to Reduce Duration of Untreated Psychosis (EaSIE)

NCT03369730 is registered in ClinicalTrials.gov with Icahn School of Medicine at Mount Sinai as lead sponsor.

NCT NCT03369730
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03369730 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Stage Identification and Engagement to Reduce Duration of Untreated Psychosis (EaSIE)
Lead sponsor
Icahn School of Medicine at Mount Sinai
Phase
Observational
Overall status
Completed
Start date
February 19, 2018
Completion date
September 15, 2021
Enrollment
94 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

at risk mental state (arms), first episode psychosis (fep)